Amilton Silva Júnior

Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology

L. Azevedo, F. Dal-Pizzol, M. Falavigna, 2020, Revista Brasileira de terapia intensiva.

[Echocardiographic assessment of cardiac resynchronization therapy: two-year follow-up period].

S. Rojas, V. Veiga, R. Vieira, 2010, Arquivos brasileiros de cardiologia.

Soluble CD137 as a potential biomarker for severe COVID-19

A. Abdo, Josiane Martin, Amilton Silva Júnior, 2022, Immunology Letters.